Genelux Corp
GNLX3.540USD
+0.030+0.85%
交易中 （美東）報價延遲15分鐘
132.04M總市值
虧損本益比TTM
關於 Genelux Corp 公司
Genelux Corporation 是一家處於臨牀後期的生物製藥公司。該公司專注於爲患有侵襲性和/或難以治療的實體腫瘤類型的患者開發下一代溶瘤病毒免疫療法。其臨牀和臨牀前候選產品旨在選擇性殺死腫瘤細胞並誘導針對患者腫瘤新抗原的強大免疫反應。其候選產品 Olvi-Vec (olvimulogene nanivacirepvec) 是一種專有的改良痘苗病毒 (VACV) 菌株，這是一種具有強大工程能力的穩定脫氧核糖核酸 (DNA) 病毒。Olvi-Vec 是根據臨牀前研究的結果開發的，用於治療多種癌症，這些研究表明 Olvi-Vec 有可能在體外和體內感染並直接殺死多種腫瘤細胞類型併產生抗腫瘤免疫反應。其產品組合還包括溶瘤痘苗免疫療法臨牀候選藥物。
公司簡介
公司代碼GNLX
公司名稱Genelux Corp
上市日期Jan 26, 2023
CEOMr. Thomas Zindrick, J.D.
員工數量24
證券類型Ordinary Share
年結日Jan 26
公司地址2625 Townsgate Road, Suite 230
城市WESTLAKE VILLAGE
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編91361
電話18052679889
網址https://genelux.com/
公司代碼GNLX
上市日期Jan 26, 2023
CEOMr. Thomas Zindrick, J.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. John Thomas, Ph.D.
Dr. John Thomas, Ph.D.
Independent Director
Independent Director
480.50K
+1.82%
Mr. Thomas Zindrick, J.D.
Mr. Thomas Zindrick, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
292.09K
+13.68%
Ms. Mary Mirabelli
Ms. Mary Mirabelli
Independent Director
Independent Director
52.00K
+317.34%
Mr. John W. Smither
Mr. John W. Smither
Independent Director
Independent Director
48.10K
+265.21%
Mr. James L. (Jim) Tyree
Mr. James L. (Jim) Tyree
Lead Independent Director
Lead Independent Director
45.79K
--
Dr. Joseph Cappello, Ph.D.
Dr. Joseph Cappello, Ph.D.
Chief Technical Officer
Chief Technical Officer
30.52K
-41.61%
Mr. Ralph Smalling
Mr. Ralph Smalling
Head - Regulatory
Head - Regulatory
18.53K
-39.41%
Mr. Eric Groen
Mr. Eric Groen
General Counsel, Corporate Secretary, Chief Compliance Officer, Head of Business Development
General Counsel, Corporate Secretary, Chief Compliance Officer, Head of Business Development
--
--
Dr. Tony Yu, Ph.D.
Dr. Tony Yu, Ph.D.
Senior Vice President - Clinical Development
Senior Vice President - Clinical Development
--
--
Mr. Matt Pulisic
Mr. Matt Pulisic
Chief Financial Officer
Chief Financial Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. John Thomas, Ph.D.
Dr. John Thomas, Ph.D.
Independent Director
Independent Director
480.50K
+1.82%
Mr. Thomas Zindrick, J.D.
Mr. Thomas Zindrick, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
292.09K
+13.68%
Ms. Mary Mirabelli
Ms. Mary Mirabelli
Independent Director
Independent Director
52.00K
+317.34%
Mr. John W. Smither
Mr. John W. Smither
Independent Director
Independent Director
48.10K
+265.21%
Mr. James L. (Jim) Tyree
Mr. James L. (Jim) Tyree
Lead Independent Director
Lead Independent Director
45.79K
--
Dr. Joseph Cappello, Ph.D.
Dr. Joseph Cappello, Ph.D.
Chief Technical Officer
Chief Technical Officer
30.52K
-41.61%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月21日 週三
更新時間: 5月21日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Szalay (Aladar)
8.40%
Woodward Diversified Capital, LLC
4.71%
The Vanguard Group, Inc.
3.38%
Bleichroeder LP
1.89%
Thomas (John)
1.27%
Other
80.35%
持股股東
持股股東
佔比
Szalay (Aladar)
8.40%
Woodward Diversified Capital, LLC
4.71%
The Vanguard Group, Inc.
3.38%
Bleichroeder LP
1.89%
Thomas (John)
1.27%
Other
80.35%
股東類型
持股股東
佔比
Investment Advisor
14.19%
Individual Investor
11.41%
Hedge Fund
2.08%
Research Firm
1.73%
Investment Advisor/Hedge Fund
1.59%
Bank and Trust
0.29%
Pension Fund
0.26%
Other
68.45%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
192
11.91M
31.55%
-354.97K
2025Q1
195
13.15M
37.48%
-1.78M
2024Q4
174
10.63M
30.79%
-4.62M
2024Q3
166
10.86M
31.45%
-4.05M
2024Q2
164
13.11M
38.15%
-670.88K
2024Q1
142
12.07M
43.82%
-1.42M
2023Q4
124
11.85M
43.27%
-65.47K
2023Q3
109
10.78M
39.96%
+2.52M
2023Q2
76
7.01M
27.00%
-28.17K
2023Q1
35
4.72M
19.71%
+3.95M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Szalay (Aladar)
3.41M
9.05%
--
--
Apr 29, 2025
Woodward Diversified Capital, LLC
1.46M
3.87%
+192.81K
+15.20%
Mar 31, 2025
The Vanguard Group, Inc.
1.28M
3.38%
+90.13K
+7.59%
Mar 31, 2025
Bleichroeder LP
714.00K
1.89%
+714.00K
--
Mar 31, 2025
Thomas (John)
446.92K
1.18%
-25.00K
-5.30%
Jun 06, 2025
BofA Global Research (US)
408.63K
1.08%
+191.53K
+88.22%
Mar 31, 2025
Geode Capital Management, L.L.C.
313.23K
0.83%
+9.91K
+3.27%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
306.78K
0.81%
-1.97K
-0.64%
Mar 31, 2025
Zindrick (Thomas)
256.95K
0.68%
-10.76K
-4.02%
May 12, 2025
Alyeska Investment Group, L.P.
285.00K
0.76%
+285.00K
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.02%
Schwab U.S. Small-Cap ETF
0%
Schwab U.S. Broad Market ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 3000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
查看更多
iShares Micro-Cap ETF
佔比0.02%
Schwab U.S. Small-Cap ETF
佔比0%
Schwab U.S. Broad Market ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
ProShares Hedge Replication ETF
佔比0%
iShares Russell 3000 ETF
佔比0%
Global X Russell 2000 Covered Call ETF
佔比0%
iShares Russell 2000 Value ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
